Compare Tilray Brands Inc (TLRY) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs Vanguard High Dividend Yield ETF — how do they compare? Tilray Brands Inc trades at $4.21 (market cap $591.60M), while Vanguard High Dividend Yield ETF trades at $163. The key difference: Vanguard High Dividend Yield ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | VYM | |
|---|---|---|
Market Cap | $591.60M | — |
Sector | Health | — |
52-Week High | $21.00 | $167.03 |
52-Week Low | $3.88 | $137.47 |
Enterprise Value | $758.73M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
VYM trades at $163.52, down 0.43% with a bearish technical signal from moving averages while oscillators remain neutral. The ETF's forward P/E ratio of 18.85x provides a valuation advantage over SPY, with financial sector exposure potentially benefiting from rising Treasury yields. Recent analysis highlights strong 16% YTD total return and lower volatility compared to the broader market.
The outlook remains cautiously optimistic given VYM's valuation discount and dividend stability, though technical weakness and yield compression to 2.20-2.22% present near-term headwinds. Key risks include sector concentration in financials and market sensitivity to interest rate changes, while institutional sentiment appears balanced between yield appeal and growth concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
